Clinical Trial Update: Safety and Tolerance Study of Alpha-Lactalbumin Enriched and Probiotic-Supplemented Infant Formula in Infants With Colic [Phase 3]

View source ↗

Summary

Phase 3 safety and tolerance study of alpha-lactalbumin enriched, probiotic-supplemented infant formula in infants with colic has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colic

Drugs mentioned

• Alpha-Lactalbumin Enriched Probiotic-Supplemented Infant Formula (Infant formula with alpha-lactalbumin enrichment and probiotic supplementation)

Snippet

Sponsor: Sodilac | Conditions: Growth, Colic | Phase 3 | Status: COMPLETED